Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE) (EPiTOMISE)
Sponsor: Duke University
Listed as NCT03178643, this PHASE4 trial focuses on Malaria,Falciparum and remains completed. Sponsored by Duke University, it has been updated 13 times since 2018, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
May 2024 — Jul 2024 [monthly]
Completed PHASE4
-
Apr 2024 — May 2024 [monthly]
Completed PHASE4
-
Feb 2021 — Apr 2024 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
▶ Show 8 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE4
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jan 2020 — Mar 2020 [monthly]
Recruiting PHASE4
-
Mar 2019 — Jan 2020 [monthly]
Recruiting PHASE4
-
Jul 2018 — Mar 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE4
-
Feb 2018 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jun 2017 — Feb 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Duke University
- National Heart, Lung, and Blood Institute (NHLBI)
For direct contact, visit the study record on ClinicalTrials.gov .